Cardinal Health stock holds near its yearly high

Published on 09/21/2026 at 15:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock closed at USD 224.95 on September 18, 2026, with an 18.5 percent gap to the USD 266.56 consensus target. Fiscal 2026 earnings growth and a 52-week range of USD 145.87 to USD 258.30 frame the valuation.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio — Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock (ISIN US14149Y1082) closed at USD 224.95 on September 18, 2026, leaving 18.5 percent upside to the USD 266.56 consensus target. The latest price snapshot also shows a market capitalization of USD 52.32 billion and a 52-week range of USD 145.87 to USD 258.30.

Fiscal 2026 still drives the debate

According to ad hoc news on September 19, 2026, Cardinal Health said all five operating segments delivered double-digit earnings growth in fiscal 2026. The same coverage said management expects those tailwinds to normalize in fiscal 2027, after specialty growth, customer onboarding and acquisitions helped lift the year.

That mix matters because the company is now asking investors to look past the one-time boost and focus on the quality of growth. According to the same ad hoc news coverage, Cardinal Health is targeting adjusted EPS growth of 13 to 15 percent a year starting from fiscal 2026.

Analysts still see room

MarketBeat said on September 21, 2026 that Cardinal Health has a consensus rating of Moderate Buy, based on 16 buy ratings and 3 hold ratings. The same overview put the average price target at USD 266.56 and the trailing earnings per share at USD 7.23.

For investors, the gap between USD 224.95 and USD 266.56 is the clearest market signal in the current setup. MarketBeat also said the stock is up 9.4 percent year to date from USD 205.62 at the start of 2026.

Stock stays below the peak

Cardinal Health stock traded between USD 221.70 and USD 226.12 in the latest session snapshot, while the 52-week high remains USD 258.30. The shares therefore sit below the peak, but still well above the 52-week low of USD 145.87.